Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 7 NIH 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Central Nervous System Neoplasms 27 Astrocytoma 15 Oligodendroglioma 14 Glioblastoma 14 Gliosarcoma 12 Glioma 11 Brain Neoplasms 11 Ependymoma 4 Spinal Cord Neoplasms 3 Neuroblastoma 3 Somatostatinoma 2 Neoplasm Metastasis 2 Melanoma 2 Medulloblastoma 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Adenoma, Islet Cell 2 Sarcoma, Ewing 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Optic Nerve Glioma 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive 1 Leukemia 1 Insulinoma 1 Glucagonoma 1 Glioma, Subependymal 1 Gastrointestinal Stromal Tumors 1 Gastrinoma 1

Interventions

azurin (50-77) 1 Temozolomide 1 Psychiatric Rehabilitation 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Neuroectodermal Tumors, Primitive × Temozolomide × Clear all

NCT02358356 2022-07-05

CONTROL NETS

Australasian Gastro-Intestinal Trials Group

Phase 2 Completed

Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡